Innovating Works
SC1-PM-12-2016
SC1-PM-12-2016: PCP - eHealth innovation in empowering the patient
Specific Challenge:Empowering the hospitalised patients, outpatients and their families/carers to support a continuum of care across a range of services can relieve the pressure on governments to provide more cost-effective healthcare systems by improving utilisation of healthcare and health outcomes. The support for patients should be understood broadly covering a continuum of care in hospital, in outpatient care, and integration back to working life. For example rare diseases are particularly difficult to manage far from specialised centres. The eHealth action plan 2012-2020[1] and the outcome of the mHealth Green paper[2]pave the way towards empowerment of the patient with the assistance of ICT.
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 16-02-2016.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Número mínimo de participantes.
Esta ayuda financia Proyectos: Objetivo del proyecto:

Specific Challenge:Empowering the hospitalised patients, outpatients and their families/carers to support a continuum of care across a range of services can relieve the pressure on governments to provide more cost-effective healthcare systems by improving utilisation of healthcare and health outcomes. The support for patients should be understood broadly covering a continuum of care in hospital, in outpatient care, and integration back to working life. For example rare diseases are particularly difficult to manage far from specialised centres. The eHealth action plan 2012-2020[1] and the outcome of the mHealth Green paper[2]pave the way towards empowerment of the patient with the assistance of ICT.


Scope:: Actions that focus on enabling the transition to new services or better integration of existing services through appropriate ICT based technologies using relevant elements e.g., proof of concept, user acceptance, use of the service, training of the professionals including online courses/forums that bring professionals and patients together, trust and security and consent of the patient. These strategies should allow communication to happen by increasing the le... ver más

Specific Challenge:Empowering the hospitalised patients, outpatients and their families/carers to support a continuum of care across a range of services can relieve the pressure on governments to provide more cost-effective healthcare systems by improving utilisation of healthcare and health outcomes. The support for patients should be understood broadly covering a continuum of care in hospital, in outpatient care, and integration back to working life. For example rare diseases are particularly difficult to manage far from specialised centres. The eHealth action plan 2012-2020[1] and the outcome of the mHealth Green paper[2]pave the way towards empowerment of the patient with the assistance of ICT.


Scope:: Actions that focus on enabling the transition to new services or better integration of existing services through appropriate ICT based technologies using relevant elements e.g., proof of concept, user acceptance, use of the service, training of the professionals including online courses/forums that bring professionals and patients together, trust and security and consent of the patient. These strategies should allow communication to happen by increasing the level of interactions between the patient and the health professionals or informal carers, sharing of data and enabling the users to stay in control of their health condition and to adhere to prescribed medical plans and contribute to increasing the effectiveness of interventions. Examples of services could contain but not limited to:

i) telemedicine services to follow patients e.g., with chronic or rare diseases after hospital discharge, and to interact with patients, carers and health professionals;

ii) e-mental health for patient empowerment with self-management tools and blended care; and

iii) domestic rehabilitation (both physical and cognitive) procedures under remote professional supervision.

Proposals should aim to develop a common language between patient and health care professionals, increase patient health and IT literacy, and foster individual patient empowerment giving the patient tools to take major life decisions and actively participate on the treatment and recovery from the disease. ICT solution should address relevant ethics and gender aspects and should also address related regulatory questions such as ownership of data, data protection/privacy and consumer protection. Open innovation with patients or/and informal carers could be included as an integral part of the concept.

The Commission considers that proposals requesting a contribution from the EU of around 4 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.


Expected Impact: Improve the quality and cost-effectiveness of healthcare systems by challenging industry from the demand side to develop innovative solutions that: increase the role and the responsibility of the patient, support self-management; reduce the number of severe episodes and complications; enhance the ICT skills and increase adherence of patients and care givers; strengthen the evidence base on health outcomes and management of comorbidities; increase the information about disease progression with advanced diagnostic techniques; provide early and predictive data about patient disease; reduce the number of unproductive visits to the hospital; and implement intensive rehabilitation programs at home when appropriate Reduced fragmentation of demand for innovative solutions to facilitate PCPs of expected minimum value of EUR 3 million by leveraging resources, encouraging among others also synergies with Structural Funds Increase the opportunities for solution uptake across wider international procurement markets by aiming at interoperable solutions that are validated through field testing by participating procurers in multiple countries across Europe and contribution to standardisation where relevant Equal access rights to the results generated by the PCP for all procurers jointly undertaken a PCP aiming for a fair and transparent level playing field for modernizing public services
Cross-cutting Priorities:Innovation ProcurementGenderSocio-economic science and humanities


[1]http://ec.europa.eu/digital-agenda/en/news/ehealth-action-plan-2012-2020-innovative-healthcare-21st-century

[2]http://ec.europa.eu/digital-agenda/en/public-consultation-green-paper-mobile-health

ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: Specific Challenge:Empowering the hospitalised patients, outpatients and their families/carers to support a continuum of care across a range of services can relieve the pressure on governments to provide more cost-effective healthcare systems by improving utilisation of healthcare and health outcomes. The support for patients should be understood broadly covering a continuum of care in hospital, in outpatient care, and integration back to working life. For example rare diseases are particularly difficult to manage far from specialised centres. The eHealth action plan 2012-2020[1] and the outcome of the mHealth Green paper[2]pave the way towards empowerment of the patient with the assistance of ICT. Specific Challenge:Empowering the hospitalised patients, outpatients and their families/carers to support a continuum of care across a range of services can relieve the pressure on governments to provide more cost-effective healthcare systems by improving utilisation of healthcare and health outcomes. The support for patients should be understood broadly covering a continuum of care in hospital, in outpatient care, and integration back to working life. For example rare diseases are particularly difficult to manage far from specialised centres. The eHealth action plan 2012-2020[1] and the outcome of the mHealth Green paper[2]pave the way towards empowerment of the patient with the assistance of ICT.
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Purchase costs.
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
Subcontracting costs.
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Amortizaciones.
Activos.
Otros Gastos.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 5:. Los elementos básicos de la innovación son integrados de manera que la configuración final es similar a su aplicación final, es decir que está listo para ser usado en la simulación de un entorno real. Se mejoran los modelos tanto técnicos como económicos del diseño inicial, se ha identificado adicionalmente aspectos de seguridad, limitaciones ambiéntales y/o regulatorios entre otros. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Please read carefully all provisions below before the preparation of your application.
 
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan).
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
 
Evaluation
3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.
3.2 Submission and evaluation process: Guide to the submission and evaluation process
      
Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
 
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Pre-Commer...
Please read carefully all provisions below before the preparation of your application.
 
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan).
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
 
Evaluation
3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.
3.2 Submission and evaluation process: Guide to the submission and evaluation process
      
Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
 
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Pre-Commercial Procurement (PCP) Cofund:
Specific provisions and funding rates
The funding rate for PCP actions is limited to 90% of the total eligible costs to leverage co-financing from the procurers in this specific case.
Standard proposal template
Standard evaluation form
Annotated Grant Agreement
Specific requirements for innovation procurement supported by Horizon 2020 grants (PCP, PPI)
 
Additional provisions:
Horizon 2020 budget flexibility
Classified information
 
Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
 
Additional documents:
H2020 Work Programme 2016-17: Introduction
H2020 Work Programme 2016-17: Health, demographic change and wellbeing
H2020 Work Programme 2016-17: Dissemination, Exploitation and Evaluation
H2020 Work Programme 2016-17: General Annexes
Legal basis: Horizon 2020 - Regulation of Establishment
Legal basis: Horizon 2020 Rules for Participation
Legal basis: Horizon 2020 Specific Programme
 
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda tiene efecto incentivador, por lo que el proyecto no puede haberse iniciado antes de la presentación de la solicitud de ayuda. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
H2020-SC1-2016-2017 PCP - eHealth innovation in empowering the patient Specific Challenge:Empowering the hospitalised patients, outpatients and their families/carers to support a continuum of care across a range...
Sin info.
SC1-PM-11-2016-2017 Clinical research on regenerative medicine
en consorcio:
Cerrada hace 8 años | Próxima convocatoria prevista para el mes de
SC1-PM-20-2017 Methods research for improved health economic evaluation
en consorcio: Specific Challenge:Health systems need to be resilient. They must be able to adapt effectively to changing environments, and tackle signific...
Cerrada hace 8 años | Próxima convocatoria prevista para el mes de
SC1-PM-03-2017 Diagnostic characterisation of rare diseases
en consorcio: Specific Challenge:Rare diseases are diseases which affect not more than 5 per 10 000 persons in the European Union. It is estimated that ra...
Cerrada hace 8 años | Próxima convocatoria prevista para el mes de
SC1-PM-16-2017 In-silico trials for developing and assessing biomedical products
en consorcio: Specific Challenge:In biomedical, pharmaceutical and toxicology research, the safety and efficacy of biomedical products is ultimately teste...
Cerrada hace 8 años | Próxima convocatoria prevista para el mes de
SC1-PM-19-2017 PPI for uptake of standards for the exchange of digitalised healthcare records
en consorcio: Specific Challenge:The use of interoperability standards is essential to the wider deployment of an EU eHealth single market. Despite previo...
Cerrada hace 8 años | Próxima convocatoria prevista para el mes de